Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-05-19FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for fluoxetine submitted by Teva Pharmaceuticals USA, Inc. (the snippet does not specify the exact c…
-
FDA approval · 2010-05-14FDA Approved: REMERON — Supplemental Application (Organon LLC)
FDA approved a supplemental application for REMERON (mirtazapine) from Organon LLC.
-
FDA approval · 2010-05-14FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Tranylcypromine sulfate (Actavis Pharma, Inc.), indicating an update to the product's approval t…
-
FDA approval · 2010-05-13FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC, authorizing a generic v…
-
FDA approval · 2010-05-03FDA Approved: PROTRIPTYLINE HYDROCHLORIDE — Original Application (Sigmapharm Laboratories, LLC)
The FDA approved an original application for Protriptyline Hydrochloride as a generic antidepressant manufactured by Sigmapharm Laboratories…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-04-27FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Actavis’s Bupropion Hydrochloride XL, extending regulatory approval for the extended-release for…
-
FDA approval · 2010-04-27FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma (ANDA), authorizing the continued marketing of th…
-
FDA approval · 2010-04-26FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for Nortriptyline Hydrochloride (PAI Pharma) under ANDA075606. The action grants approval of the…
-
FDA approval · 2010-04-22FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Bupropion hydrochloride tablets from Aurobindo Pharma Limited.
-
FDA approval · 2010-04-16FDA Approved: IMIPRAMINE PAMOATE — Original Application (Hikma Pharmaceuticals USA Inc)
FDA approves the original application for Imipramine Pamoate (generic) from Hikma Pharmaceuticals USA Inc. for use in treating depression an…
-
FDA approval · 2010-04-16FDA Approved: IMIPRAMINE PAMOATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' imipramine pamoate as an Original Application (generic) under the ANDA process for the same indications …
-
FDA approval · 2010-04-08FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original ANDA for Bupropion Hydrochloride from Aurobindo Pharma Limited. This approval adds a generic option for the indica…
-
FDA approval · 2010-04-07FDA Approved: VENLAFAXINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for Venlafaxine hydrochloride, a generic version of venlafaxine.
-
FDA approval · 2010-04-06FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original application for generic bupropion hydrochloride tablets. The product is indicated for m…
-
FDA approval · 2010-04-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
The FDA approved a supplemental application for Bupropion hydrochloride from Epic Pharma LLC, granting approval for this generic product.
-
FDA approval · 2010-03-25FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental ANDA for Desipramine hydrochloride from Actavis Pharma, Inc., supporting the generic product's approval.
-
FDA approval · 2010-03-25FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Desipramine Hydrochloride from Actavis Pharma, Inc.
-
FDA approval · 2010-03-25FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Desipramine Hydrochloride from Actavis Pharma, enabling the marketing of a generic version.
-
FDA approval · 2010-03-25FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for paroxetine hydrochloride hemihydrate from Mylan Pharmaceuticals Inc., advancing the generic …
-
FDA approval · 2010-03-25FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for paroxetine hydrochloride from Apotex Corp., granting approval for an additional generic product.
-
FDA approval · 2010-03-22FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved a generic version of fluoxetine hydrochloride (an SSRI) from Dr. Reddy's Laboratories Limited under an Original Application (AN…
-
FDA approval · 2010-03-15FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA076690.
-
FDA approval · 2010-03-11FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application submitted by BluePoint Laboratories for venlafaxine (venlafaxine hydrochloride) as a generic product…
-
FDA approval · 2010-03-11FDA Approved: IMIPRAMINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approval of a new generic imipramine hydrochloride product from Lupin Pharmaceuticals (ANDA 090441).
-
FDA approval · 2010-02-26FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Wellbutrin SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC, updating the produ…